meta-analysis | Q815382 |
systematic review | Q1504425 |
scholarly article | Q13442814 |
P50 | author | Miia Kivipelto | Q16299902 |
Kristine Yaffe | Q18749055 | ||
Carol Brayne | Q29642394 | ||
Peter W de Leeuw | Q46001914 | ||
Frans RJ Verhey | Q68596187 | ||
P2093 | author name string | John M Starr | |
Sebastian Köhler | |||
Kate Irving | |||
Martin P J van Boxtel | |||
Kay Deckers | |||
Ileana Camerino | |||
P2860 | cites work | Global prevalence of dementia: a Delphi consensus study | Q24603249 |
A new equation to estimate glomerular filtration rate | Q24651973 | ||
How to measure renal function in clinical practice | Q24672086 | ||
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation | Q40542438 | ||
Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus | Q43750856 | ||
Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE study | Q43943476 | ||
Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. | Q44022561 | ||
Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease | Q44206000 | ||
Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study | Q44948991 | ||
Chronic kidney disease: a risk factor for dementia onset: a population-based study. The Osaki-Tajiri Project. | Q45827024 | ||
Level of kidney function correlates with cognitive decline. | Q45967517 | ||
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study | Q46512603 | ||
Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B. | Q46834063 | ||
Subclinical vascular disease of the brain in dialysis patients | Q48126601 | ||
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
Excerpts from the United States Renal Data System 2006 Annual Data Report. | Q50795168 | ||
Kidney function is related to cerebral small vessel disease. | Q51899375 | ||
Serum Creatinine Concentration and Risk of Cardiovascular Disease | Q57653889 | ||
Chronic kidney disease and the ageing population | Q63681858 | ||
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation | Q77357987 | ||
Interpreting and investigating proteinuria | Q83854126 | ||
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data | Q30836810 | ||
Risk factors for late-life cognitive decline and variation with age and sex in the Sydney Memory and Ageing Study | Q31120480 | ||
CKD associates with cognitive decline | Q33561710 | ||
A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study | Q33741459 | ||
Kidney function and cognitive health in older adults: the Cardiovascular Health Study | Q33806588 | ||
Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C) | Q34181739 | ||
Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis | Q34255325 | ||
Chronic kidney disease: global dimension and perspectives | Q34347984 | ||
Biochemistry and clinical role of human cystatin C. | Q34377103 | ||
Clinical Interaction between Brain and Kidney in Small Vessel Disease | Q34512756 | ||
Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresis | Q34576418 | ||
Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals | Q34978336 | ||
Kidney function and cognitive performance and decline in older men. | Q35025811 | ||
Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States | Q35421577 | ||
Cystatin C and cognitive impairment 10 years later in older women | Q35661812 | ||
Kidney dysfunction and cognitive decline in women | Q35827309 | ||
Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study | Q35888130 | ||
Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging | Q35981826 | ||
Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults | Q36493190 | ||
Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly | Q36702716 | ||
Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden | Q36824922 | ||
The projected effect of risk factor reduction on Alzheimer's disease prevalence | Q36825862 | ||
Cystatin C as a marker of cognitive function in elders: findings from the health ABC study | Q36976287 | ||
Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory | Q37000226 | ||
Cognitive function in chronic kidney disease | Q37077771 | ||
Serum cystatin C and the risk of Alzheimer disease in elderly men | Q37179085 | ||
Kidney function is associated with the rate of cognitive decline in the elderly. | Q37368380 | ||
Guanidino compounds as uremic (neuro)toxins | Q37587275 | ||
Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life | Q37765089 | ||
Cognitive disorders and dementia in CKD: the neglected kidney-brain axis | Q38071864 | ||
Estimated glomerular filtration rate | Q38181973 | ||
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies | Q38287482 | ||
Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies | Q38495525 | ||
Kidney function and cognitive and functional decline in elderly adults: findings from the Singapore longitudinal aging study | Q39602050 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dementia | Q83030 |
P304 | page(s) | 198-208 | |
P577 | publication date | 2016-12-14 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies | |
P478 | volume | 88 |
Q90324916 | A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease |
Q48092039 | A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain |
Q99629984 | Atherosclerosis, its risk factors, and cognitive impairment in older adults |
Q90083831 | Common bacterial infections and risk of incident cognitive decline or dementia: a systematic review protocol |
Q92893220 | Diet-Related Metabolites Associated with Cognitive Decline Revealed by Untargeted Metabolomics in a Prospective Cohort |
Q47242001 | Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort |
Q57113713 | Hypertensive organ damage predicts future cognitive performance: A 9-year follow-up study in patients with hypertension |
Q91654120 | Machine learning prediction of incidence of Alzheimer's disease using large-scale administrative health data |
Q91834957 | Moderately increased albuminuria, chronic kidney disease and incident dementia: the HUNT study |
Q49825558 | Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease |
Q92054777 | Preventing dementia by preventing stroke: The Berlin Manifesto |
Q91344902 | Serum xanthophyll carotenoids are associated with estimated glomerular filtration rate in an aged cohort |
Q90079322 | The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis |
Q91987577 | Urine dicarboxylic acids change in pre-symptomatic Alzheimer's disease and reflect loss of energy capacity and hippocampal volume |
Search more.